ADIM
AMRS

Alpha DNA Investment Management’s Amyris Inc. AMRS Stock Holding History

Alpha DNA Investment Management’s Portfolio AMRS Stock Details AMRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-156
Closed -$2K – 716
2021
Q1 		$2K Buy
+156
New +$2.26K ﹤0.01% 597

Other funds holding AMRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Alpha DNA Investment Management's AMRS Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Amyris Inc. (AMRS) in Q2 2021, closing a stake of 156 shares — an estimated $2K sold.

Alpha DNA Investment Management first reported a position in AMRS in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 186 funds tracked by Wall St. Rank hold AMRS as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Amyris Inc. position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 156 Amyris Inc. shares in Q2 2021, an estimated $2K.
  • Alpha DNA Investment Management first reported a position in Amyris Inc. in Q1 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's Amyris Inc. position peaked at $2K in Q1 2021.
  • 186 funds tracked by Wall St. Rank held Amyris Inc. as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.